HCV Archives -

How direct-acting antivirals are transforming treatment of hepatitis C.

Access and elimination: the future of DAAs in hepatitis C

https://pharmaphorum.com/views-and-analysis/access-elimination-future-daas-hepatitis-c/

Gilead has led a revolution in curing hepatitis C, but now faces a slowdown.

Many millions still untreated – but hep C boom is already over

https://pharmaphorum.com/views-and-analysis/many-millions-left-untreated-hepatitis-c-boom-already/

European safety experts are reviewing the latest generation of hepatitis C drugs following cases of re-activation of hepatitis

European safety experts review latest hepatitis C drugs

https://pharmaphorum.com/news/european-safety-experts-review-latest-hepatitis-c-drugs/

David Rowlands’ latest online poll examines the impact of stigma on people diagnosed with hepatitis C virus (HCV).

Hepatitis C: breaking down the stigma

https://pharmaphorum.com/views-and-analysis/hepatitis-c-breaking-stigma/

AbbVie aiming to steal market share from Gilead

AbbVie’s hep C combination approved in Europe

https://pharmaphorum.com/news/abbvies-hep-c-combination-approved-in-europe/

HCV